CLASS A COMMON SHARE PURCHASE WARRANT Edesa Biotech, Inc.Securities Agreement • November 3rd, 2022 • Edesa Biotech, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 3rd, 2022 Company IndustryTHIS CLASS A COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any date that is the earlier to occur of 60 days from November 2, 2022 (the “Closing Date”) or the date a registration statement for the Company’s common shares (“Common Shares”) is declared effective (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (Toronto time) on the third (3rd) anniversary of the Initial Exercise Date (the “Termination Date”), but not thereafter, to subscribe for and purchase from Edesa Biotech, Inc., a British Columbia corporation (the “Company”), up to [●] Common Shares under this Warrant (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
CLASS B COMMON SHARE PURCHASE WARRANT Edesa Biotech, Inc.Securities Agreement • November 3rd, 2022 • Edesa Biotech, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 3rd, 2022 Company IndustryTHIS CLASS B COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time at any day that is the earlier to occur of 60 days from November 2, 2022 (the “Closing Day”) or the date a registration statement for the Company’s common shares (“Common Shares”) is declared effective (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (Toronto time) on the twelve month anniversary of the Initial Exercise Date (the “Termination Date”), but not thereafter, to subscribe for and purchase from Edesa Biotech, Inc., a British Columbia corporation (the “Company”), up to [●] Common Shares under this Warrant (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).